Outcome of the Board Meeting held on 11.06.2025
IREDA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IREDA's Board approved the allotment of 12.14 crore equity shares to qualified institutional buyers under a Qualified Institutions Placement (QIP) at ₹165.14 per share, aggregating to ₹2,005.90 crore. The issue price includes a premium of ₹155.14 over the face value of ₹10, but was set at a 5% discount (₹8.69) to the floor price determined under SEBI ICDR rules. Post-allotment, the company's paid-up equity capital has increased from ₹2,687.76 crore to ₹2,809.23 crore. Key allottees include LIC (50%), Morgan Stanley Asia Singapore (9.12%), Societe Generale (8.98%), and Vikasa India EIF I Fund (5.13%).
The QIP raises ₹2,005.90 crore of fresh equity capital for IREDA, strengthening its balance sheet for renewable energy financing. The allotment of 12.14 crore new shares (about 4.5% dilution) and the fact that marquee investors like LIC and Morgan Stanley took significant stakes could be viewed positively, though the 5% discount to floor price and near-term dilution may put mild pressure on the stock.